S-Propargyl-Cysteine Remodels the Gut Microbiota to Alleviate Rheumatoid Arthritis by Regulating Bile Acid Metabolism
BackgroundRheumatoid arthritis (RA) is a long-term autoimmune disorder characterized by chronic inflammation that results in swollen and painful joints and even cartilage and bone damage. The gut microbiota, a novel anti-inflammatory target, is considered an important environmental factor in the dev...
Main Authors: | Zhou Wang, Yue Yu, Junyi Liao, Wei Hu, Xiqing Bian, Jianlin Wu, Yi Zhun Zhu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-08-01
|
Series: | Frontiers in Cellular and Infection Microbiology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcimb.2021.670593/full |
Similar Items
-
H2S donor S‐propargyl‐cysteine for skin wound healing improvement via smart transdermal delivery
by: Xiaoqing Zhao, et al.
Published: (2024-03-01) -
S-propargyl-cysteine attenuates inflammatory response in rheumatoid arthritis by modulating the Nrf2-ARE signaling pathway
by: Wei-Jun Wu, et al.
Published: (2016-12-01) -
S-propargyl-cysteine promotes the stability of atherosclerotic plaque via maintaining vascular muscle contractile phenotype
by: Li Ping, et al.
Published: (2024-01-01) -
S-Propargyl-Cysteine Attenuates Diabetic Cardiomyopathy in db/db Mice Through Activation of Cardiac Insulin Receptor Signaling
by: Ye Li, et al.
Published: (2021-09-01) -
S-Propargyl-Cysteine Ameliorates Peripheral Nerve Injury through Microvascular Reconstruction
by: Haiyan Xi, et al.
Published: (2023-01-01)